Choosing pharmacotherapy for ILD in patients with connective tissue disease

Interstitial lung disease (ILD) is a well-recognised complication of several connective tissue diseases (CTD). This article outlines the various treatment options for the most common CTD-ILDs and discuss the ongoing research in this field. https://bit.ly/39NHwx6

Detalles Bibliográficos
Autores principales: Wu, Zhe, Molyneaux, Philip L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753625/
https://www.ncbi.nlm.nih.gov/pubmed/35035571
http://dx.doi.org/10.1183/20734735.0114-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753625/
https://www.ncbi.nlm.nih.gov/pubmed/35035571
http://dx.doi.org/10.1183/20734735.0114-2021

Ejemplares similares